Substantial basic science and clinical evidence suggests that excess tumor necrosis factor-alpha (TNF-alpha) is centrally involved in the pathogenesis of Alzheimer's disease. In addition to its ...

Explore the safety and efficacy of switching to etanercept biosimilars, backed by clinical trials and real-world evidence for ...

The RENEWAL trial combined data that were collected in the Randomized Etanercept North American Strategy to Study Antagonism of Cytokines (RENAISSANCE) trial in North America and the Research into ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit. The first ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit. The first ...

Please provide your email address to receive an email when new articles are posted on . Originator- and biosimilar-receiving patients with rheumatoid arthritis demonstrated similar disease activity at ...

Real-world data suggest anti-TNF biosimilars for juvenile idiopathic arthritis offer comparable efficacy and safety to their brand name counterparts. As high-cost originator biologics continue to ...